Synthesis of radioiodinated probes targeted toward matrix metalloproteinase-12
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (2) , 193-195
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Selective Matrix Metalloprotease 12 Inhibitor for Potential Treatment of Chronic Obstructive Pulmonary Disease (COPD): Discovery of (S)-2-(8-(Methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408)Journal of Medicinal Chemistry, 2009
- The selective MMP‐12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smokeBritish Journal of Pharmacology, 2008
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung MetastasesCancer Research, 2006
- Definition, epidemiology, and risk factorsBMJ, 2006
- Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax, 2006
- Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airwaysInternational Immunopharmacology, 2005
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Human and mouse proteases: a comparative genomic approachNature Reviews Genetics, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002